SCHEMBL7543901

SCHEMBL7543901

[CH2]c1ccc(OC(=O)OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 3/20 0.45
HSD17B10 Q99714 2/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 2/20 0.45
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP14 P50281 1/20 0.42
ELANE P08246 5/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676909 0.89 KMT2A (0.58) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL697317 0.82 CA1 (0.56) KMT2AMEN1ALDH1A1LMNAHTT
SCHEMBL6936328 0.82 MMP2 (0.55) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL8779173 0.82 KMT2A (0.52) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL1598492 0.80 LMNA (0.61) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL8830906 0.80 KMT2A (0.50) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL26078890 0.80 LMNA (0.61) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL9640657 0.79 KMT2A (0.46) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL20364760 0.79 THRB (0.56) KMT2AMEN1ALDH1A1HSD17B10LMNA
SCHEMBL24419014 0.78 KMT2A (0.52) KMT2AMEN1ALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200454-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE Novuspharma S.p.A. (IT) 2002-05-02 EP claimed
WO-2001009149-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE NOVUSPHARMA S.P.A. (IT) 2001-02-08 WO claimed
CN-111234180-B Resin composition and hardened resin composition 财团法人工业技术研究院 2022-06-14 CN disclosed
CN-111234180-A Resin composition and hardened resin composition 财团法人工业技术研究院 2020-06-05 CN disclosed
EP-1200454-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE Novuspharma S.p.A. (IT) 2002-05-02 EP disclosed
WO-2001009149-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE NOVUSPHARMA S.P.A. (IT) 2001-02-08 WO disclosed
US-5614498-A OLIGOPEPTIDES, BRONCHDILATORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-03-25 US disclosed
US-5496928-A Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
EP-0555537-A2 Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-08-18 EP disclosed